Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives

The introduction of immunotherapies has been a major development in the treatment of many advanced cancers, including hepatocellular carcinoma (HCC). We are entering a new era of systemic therapy for advanced HCC associated with an explosion of clinical trial activity. Data from phase I/II studies o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Weiqi, Liu, Ken, Chen, Minjiang, Sun, Jin-Yu, McCaughan, Geoffrey W, Lu, Xiao-Jie, Ji, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651675/
https://www.ncbi.nlm.nih.gov/pubmed/31384311
http://dx.doi.org/10.1177/1758835919862692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651675/
https://www.ncbi.nlm.nih.gov/pubmed/31384311
http://dx.doi.org/10.1177/1758835919862692

Ejemplares similares